CytomX Therapeutics Inc (CTMX)

CytomX Therapeutics Inc (CTMX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $556M; returns 1 day -4.9%, 1 week +1.8%, 1 year -29.7%.

CytomX Therapeutics Inc. (CTMX) is a clinical-stage oncology-focused biopharmaceutical company pioneering novel conditionally activated, masked biologic therapeutics utilizing its proprietary PROBODY® therapeutic platform.

Groups CTMX belongs to

• Biotechnology
• Oncology
• Clinical Stage Biotech
• Healthcare
• Biopharmaceutical
• Antibody-Drug Conjugates
• Clinical Stage
• Antibody Therapeutics
• Cancer Therapeutics
• Immunotherapy
• Strategic Partnerships

CTMX financial model: income statement, cash flow and balance sheet